Table 2 Expression of TRPS1 and GATA3 in special types of BCs
From: TRPS1, a sensitive marker for different histological and molecular types of breast cancer
Histologic type | Molecular subtype | TRPS1 | GATA3 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Negative | Low | moderate | High | Total positive (%) | Negative | Low | moderate | High | Total positive (%) | ||
invasive micropapillary carcinoma | Luminal/HER2 + /triple negative | 1 | 1 | 1 | 266 | 99.26% (267/269) | 0 | 4 | 4 | 261 | 98.51% (265/269) |
invasive lobular carcinoma | Luminal/HER2 + /triple negative | 0 | 1 | 0 | 243 | 99.59% (243/244) | 0 | 0 | 0 | 244 | 100% (244/244) |
mucinous carcinoma | luminal | 0 | 0 | 0 | 63 | 100% (63/63) | 0 | 0 | 0 | 63 | 100% (63/63) |
ER-positive neuroendocrine tumor | luminal | 0 | 1 | 0 | 38 | 97.44% (38/39) | 0 | 0 | 0 | 34 | 100% (34/34) |
triple-negative neuroendocrine carcinoma | triple negative | 5 | 2 | 0 | 0 | 0% (0/7) | 6 | 0 | 0 | 0 | 0% (0/6) |
adenoid cystic carcinoma | triple negative | 0 | 0 | 2 | 5 | 100% (7/7) | 3 | 0 | 0 | 0 | 0% (0/3) |
tubular carcinoma | luminal | 0 | 0 | 0 | 4 | 100% (4/4) | 0 | 0 | 0 | 4 | 100% (4/4) |
secretory carcinoma | triple negative | 0 | 0 | 0 | 2 | 100% (2/2) | 0 | 0 | 0 | 2 | 100% (2/2) |